BAP31, a promising target for the immunotherapy of malignant melanomas
2015 · Journal of Experimental & Clinical Cancer Research · 24 citations
https://doi.org/10.1186/s13046-015-0153-6
Nanfang Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
110
Citations
2
h-index
2
i10-index
Shuzhi Yu is an academic researcher from Nanfang Hospital. The author has contributed to research in topics: Technology Adoption and User Behaviour & Immunotherapy and Immune Responses & Digital Marketing and Social Media. The author has an h-index of 2, co-authored 5 publications.
Click to start Chat